- Home
- BEAT vs CATO Comparison
BEAT vs CATO Comparison
Compare BEAT & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BEAT | CATO |
|---|---|---|
| Founded | 2015 | 1946 |
| Country | United States | United States |
| Employees | 16 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Clothing/Shoe/Accessory Stores |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.2M | 59.6M |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | BEAT | CATO |
|---|---|---|
| Price | $1.16 | $2.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.75 | N/A |
| AVG Volume (30 Days) | ★ 827.3K | 56.8K |
| Earning Date | 03-12-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.09 |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $649,806,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $260.78 | N/A |
| P/E Ratio | ★ N/A | $11.20 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.54 | $2.19 |
| 52 Week High | $4.00 | $4.92 |
Technical Indicators
Market Signals| Indicator | BEAT | CATO |
|---|---|---|
| Relative Strength Index (RSI) | 36.54 | 35.51 |
| Support Level | $0.91 | N/A |
| Resistance Level | $1.35 | $3.22 |
| Average True Range (ATR) | 0.09 | 0.16 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 16.47 | 3.23 |
Price Performance
Historical ComparisonAbout BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.